PRIDOPIDINE
Total Payments
$673,569
Transactions
124
Doctors
5
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $673,569 | 124 | 5 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $533,264 | 92 | 79.2% |
| Consulting Fee | $138,500 | 19 | 20.6% |
| Travel and Lodging | $1,604 | 10 | 0.2% |
| Food and Beverage | $200.73 | 3 | 0.0% |
Payments by Type
Research
$533,264
92 transactions
General
$140,304
32 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| TV7820-CNS-20002 | Teva Pharmaceuticals USA, Inc. | $272,559 | 0 |
| TV7820-CNS-20016 | Teva Pharmaceuticals USA, Inc. | $87,497 | 0 |
| ARC16C015 | Teva Pharmaceuticals USA, Inc. | $73,267 | 0 |
| ACR16C015 | Teva Pharmaceuticals USA, Inc. | $57,341 | 0 |
| ACTA-RIFX-2015 | Teva Pharmaceuticals USA, Inc. | $42,601 | 0 |
Top Doctors Receiving Payments for PRIDOPIDINE
Ad
Manufacturing Companies
- Teva Pharmaceuticals USA, Inc. $673,569
Product Information
- Type Drug
- Total Payments $673,569
- Total Doctors 5
- Transactions 124
About PRIDOPIDINE
PRIDOPIDINE is a drug associated with $673,569 in payments to 5 healthcare providers, recorded across 124 transactions in the CMS Open Payments database. The primary manufacturer is Teva Pharmaceuticals USA, Inc..
Payment data is available from 2017 to 2017. In 2017, $673,569 was paid across 124 transactions to 5 doctors.
The most common payment nature for PRIDOPIDINE is "Unspecified" ($533,264, 79.2% of total).
PRIDOPIDINE is associated with 5 research studies, including "TV7820-CNS-20002" ($272,559).